Arcadia, CA, United States of America

T (Tom) Taniguchi

This inventor holds 1 USPTO granted patent. Top assignee: Alpha Therapeutic Corporation. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of T (Tom) Taniguchi

Introduction

T (Tom) Taniguchi is a notable inventor based in Arcadia, CA (US). He has made significant contributions to the field of protein purification. His work has led to advancements in the processing of alpha-1 proteinase inhibitors, which are crucial in various medical applications.

Latest Patents

Taniguchi holds a patent for a process titled "Process for separating α1-proteinase inhibitor from Cohn fraction IV1 and IV4 paste." This invention focuses on purifying α1-proteinase inhibitor through a series of steps involving precipitation with polyethylene glycol (PEG) and subsequent recovery using anion-exchange and metal chelate mediums. The purified alpha-1 proteinase inhibitor boasts a specific activity greater than 0.6 units/mg, showcasing the effectiveness of his method.

Career Highlights

Taniguchi is associated with Alpha Therapeutic Corporation, where he has applied his expertise in protein purification. His work has contributed to the development of therapeutic products that utilize purified proteins for medical treatments. His innovative approach has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Throughout his career, Taniguchi has collaborated with esteemed colleagues such as John Mark Rolf and Prabir Bhattacharya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

T (Tom) Taniguchi's contributions to the field of protein purification exemplify the impact of innovation in biotechnology. His patented process for purifying alpha-1 proteinase inhibitors highlights his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…